This is a professional and in-depth study on the current state of the Genome Editing Market with a basic overview of the Market including definitions, classifications, applications and Market chain structure. The strategic insights and development plans are also discussed and manufacturing processes and cost structures analyzed. Genome Editing Market import/export consumption, supply and demand figures and cost price and production value gross margins are also provided

An exclusive Genome Editing Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.

According to our new research study on “Genome Editing Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Technology, Application, and End User,” the market is expected to grow from US$ 5.19 billion in 2021 to US$ 16.98 billion by 2028; it is estimated to grow at a CAGR of 18.4% during 2021–2028.  Factors driving the growth of the market are the rising prevalence of cancer, growing rate of genetic disorders, and rapidly growing research and development initiatives around gene editing tools and techniques.

Request sample pages of this research study at –

The prominent/emerging players in the Genome Editing Market research include:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza
  • Horizon Discovery Group plc.
  • Integrated DNA Technologies
  • GenScript
  • New England Biolabs
  • Eurofins Scientific
  • CRISPR Therapeutics
  • Editas Medicine

Based on technology, the genome editing market is segmented into CRISPR, TALEN, antisense, and other. The CRISPR segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. The market growth for this segment is attributed to incumbent usage of CRISPR, high volume consumption, and product innovation. CRISPR-Cas9 is faster, cheaper, and more accurate than the other technologies of DNA editing and is used for the wide applications. It is the simplest, most versatile, and precise method of genetic manipulation. Companies like Sangamo Therapeutics, Editas Medicine, Thermo Fisher Scientific, and Horizon Discovery Groups offer CRISPR.

Speak to analyst for more details: –

The table of content for Market research study includes:

  • Introduction
  • Key takeaways
  • Research methodology
  • Market landscape
  • key market dynamics
  • Global market analysis
  • Revenue and forecasts to 2028 – type
  • Revenue and forecasts to 2028 – type of product
  • Revenue and forecasts to 2028 – service
  • Revenue and forecasts to 2028 – geographical analysis
  • Impact of covid-19 pandemic on global market
  • Industry landscape
  • key company profiles
  • Appendix
  • List of tables
  • List of figures

Company overview:

Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.

Product benchmarking:

Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.

Strategic initiatives:

Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.

About us:                                                           

The insight partners are a one stop Market research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as semiconductor and electronics, aerospace and defense, automotive and transportation, healthcare it, manufacturing and construction, medical device, technology, media and telecommunications, chemicals and materials.

Contact us:                                                                                                         

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876                                                    

Asia-pacific: +91 20 6727 8686